After four years, those who took GLP-1 drugs had a 7% lower risk of developing an obesity-related cancer and an 8% lower risk ...

Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related ...

The findings add to other research showing a lower risk of obesity-related cancers in patients taking GLP-1 drugs, a class of ...

Replacing animal products with plant-based foods—even those defined as "unhealthy" by the plant-based diet index—is an ...

Balancing best practices with patient affordability and literacy. Here’s how one doctor adapts treatment plans for real-world ...

A pioneering immunotherapy drug to treat type 1 diabetes is soon to be tested on human participants for the first time.

New review confirms psychiatric safety of commonly used glucagon-like peptide 1 receptor agonists among patients without ...

For several years, researchers have known that hyperactivity of a subset of ... Adult-Onset Type 1 Diabetes Increases Risk of Cardiovascular Disease and Death May 14, 2025 — A new study shows ...

Various studies have pointed toward GLP-1 RAs causing mental health complications, such as anxiety and depression. The National Institutes of Health (NIH) published research in June 2024 that ...